Sökning: "Likelihood ratio test"
Visar resultat 1 - 5 av 55 avhandlingar innehållade orden Likelihood ratio test.
1. Likelihood-Based Tests for Common and Idiosyncratic Unit Roots in the Exact Factor Model
Sammanfattning : Dynamic panel data models are widely used by econometricians to study over time the economics of, for example, people, firms, regions, or countries, by pooling information over the cross-section. Though much of the panel research concerns inference in stationary models, macroeconomic data such as GDP, prices, and interest rates are typically trending over time and require in one way or another a nonstationary analysis. LÄS MER
2. Contributions to Estimation and Testing Block Covariance Structures in Multivariate Normal Models
Sammanfattning : This thesis concerns inference problems in balanced random effects models with a so-called block circular Toeplitz covariance structure. This class of covariance structures describes the dependency of some specific multivariate two-level data when both compound symmetry and circular symmetry appear simultaneously. LÄS MER
3. Semiparametric survival models for routine register data
Sammanfattning : Routine registers offer researchers opportunities to carry out studies of covariate effects on lifetimes of rare diseases otherwise infeasible because of the large cohorts required. Familial relationships necessary for analysis of environmental or genetic factors can be identified by record linking. LÄS MER
4. Assessment of balance control in relation to fall risk among older people
Sammanfattning : Falls and their consequences among older people are a serious medical and public health problem. Identifying individuals at risk of falling is therefore a major concern. LÄS MER
5. Methods for handling model misspecification in pharmacometric model-based approaches for the analysis of longitudinal clinical trial data
Sammanfattning : Pharmacometrics model-based analyses proved to be increasingly useful in drug discovery and development. This usefulness was made evident by the formalisation of the model-integrated drug discovery and development framework (MID3). LÄS MER